Effectiveness of Eplerenone to Improve Target Organ Damage in Patients With Resistant Arterial Hypertension
PHASE3CompletedINTERVENTIONAL
Enrollment
85
Participants
Timeline
Start Date
January 31, 2007
Primary Completion Date
May 31, 2008
Study Completion Date
July 31, 2008
Conditions
Essential Hypertension
Interventions
DRUG
placebo
od
DRUG
eplerenone
50mg od
Trial Locations (1)
91054
CRC Medical Department IV, Erlangen
All Listed Sponsors
lead
University of Erlangen-Nürnberg Medical School
OTHER
NCT00138944 - Effectiveness of Eplerenone to Improve Target Organ Damage in Patients With Resistant Arterial Hypertension | Biotech Hunter | Biotech Hunter